共 298 条
[1]
Tang N(2020)Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia J Thromb Haemost 18 844-847
[2]
Li D(2020)Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy J Thromb Thrombolysis 50 278-280
[3]
Wang X(2020)High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study Intensive Care Med 46 1089-1098
[4]
Sun Z(2020)COVID19 coagulopathy in Caucasian patients Br J Haematol 189 1044-1049
[5]
Belen-Apak FB(2020)The old but new: can unfractionated heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases? Med Hypotheses 142 834-841
[6]
Sarıalioğlu F(1993)Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate Virology 193 13-17
[7]
Helms J(2015)Novel heparan sulfate-binding peptides for blocking herpesvirus entry PLoS ONE 10 1700-1715
[8]
Tacquard C(2017)Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells Antiviral Res 140 e01987-e2020
[9]
Severac F(2020)Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the Spike S1 receptor-binding domain with heparin Thromb Haemost 120 1043-1057.e15
[10]
Fogarty H(2021)Effective inhibition of SARS-CoV-2 entry by heparin and enoxaparin derivatives J Virol 95 11727-11734